SHANNON DISHMAN: Open Payments
NPI 1396204319 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,207 in 111 payments from 17 companies in 2025. Trend: 2023 $2,522 · 2024 $14,625 · 2025 $13,207
Speaker / faculty: $9,276Food & beverage: $2,823Travel & lodging: $1,054Education: $54
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $7,224 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $4,903 |
| Janssen Biotech, Inc. | 12 | $278 |
| Sumitomo Pharma America, Inc. | 5 | $128 |
| PFIZER INC. | 7 | $119 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Celltrion USA Inc. | 4 | $74 |
| Ipsen Biopharmaceuticals, Inc | 3 | $72 |
| Ardelyx, Inc. | 3 | $72 |
| Gilead Sciences, Inc. | 3 | $66 |
Products named: SKYRIZI, ENTYVIO, RINVOQ, TREMFYA, GEMTESA, DUPIXENT, VEGZELMA, IQIRVO.
Industry payments across VA — which companies pay providers there.
